--Net Revenues up 95.9% year over year in the fourth quarter –
--Net Revenues up 372.2% year over year in full year–
DALIAN, China, April 11, 2022 /PRNewswire/ — CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading lithium-ion battery manufacturer and electric energy solution provider in China, today reported its unaudited financial results for the fourth quarter and full year of 2022 ended December 31, 2022.
Fourth Quarter of 2022 Financial Highlights
- Net revenues were $54.46 million, an increase of 95.9% from $27.80 million in the same period of 2021.
- Net revenues from batteries used in light electric vehicles were $4.51 million, up by 1035.5% from $0.40 million in the same period of 2021.
- Net revenues from batteries used in electric vehicles were $4.68 million, increased by 3,169.2% from $0.14 million in the same period of 2021.
- Net revenues from uninterruptible supplies were $18.95 million, up by 101.7% from $9.40 million in the same period of 2021.
- Net revenues from manufacturing and sales of raw materials were $26.33 million, up by 47.4% from $17.87 million in the same period of 2021.
- Gross profit was $3.78 million, representing an increase of $2.74 million, or 263.1%, from gross profit of $1.04 million for the same period in 2021.
Full Year of 2022 Financial Highlights
- Net revenues were $248.73 million, an increase of 372.2% from $52.67 million in 2021.
- Net revenues from batteries used in light electric vehicles were $6.42 million, up by 775.2% from $0.73 million in 2021.
- Net revenues from batteries used in electric vehicles were $4.69 million, increased by 1,824.2% from $0.24 million in 2021.
- Net revenues from uninterruptible supplies were $83.60 million, up by 151.0% from $33.31 million in 2021.
- Net revenues from manufacturing and sales of raw materials were $154.01 million, up by 762.1% from $17.87 million in 2021.
- Gross profit was $18.10 million, an increase of 254.0% from $5.11 million in 2021.
Yunfei Li, Chairman and Chief Executive Officer of the Company, commented: "In 2022, we are pleased to see our revenues grow by 372.2% from the previous year to more than $200 million, despite the challenges posed by COVID-19 in China. We have secured partnerships with several key and internationally renowned clients in the industry, including those that we have chosen to not identify in public announcements so far to maintain our competitive edge. As of March 31, 2023, we have in total received orders worth $180 million to be delivered. With the market's increasing recognition of our brand, we anticipate that our financial results will show further growth in 2023."
Mr. Li continued: "In 2022, the price of lithium carbonate, a key raw material for lithium batteries, skyrocketed by about 300%, which is an important factor affecting our profitability in 2022. However, starting from 2023, its price declined quickly, and the momentum will remain. With that, we are optimistic about our financial outlook this year."
Xiangyu Pei, Interim Chief Financial Officer of the Company, noted: "Our management team is dedicated to effectively controlling our expenses. In 2022, despite integrating a newly acquired raw material business, our sales and marketing expenses reduced by 12.77%, and our general and administrative expenses dropped by 2.89%. As we look ahead, we believe that we can deliver a better result in 2023."
Fourth Quarter of 2022 Financial Results
Net revenues were $54.46 million, an increase of 95.9% from $27.80 million in the same period of 2021. This was driven mostly by strong sales of high-power lithium batteries and materials for use in manufacturing lithium battery.
Net Revenues by End-product Applications | 2021 Fourth Quarter | 2022 Quarter | % Change | |||||||
Segment 1 High power lithium batteries used in: | ||||||||||
Uninterruptible supplies | $9,396 | $18,948 | 101.7 | |||||||
Light electric vehicles | 397 | 4,508 | 1,035.5 | |||||||
Electric vehicles | 143 | 4,675 | 3,169.2 | |||||||
Segment 2 Materials for use in manufacturing of lithium battery cell Precursor Cathode |
9,139 8,726 |
17,076 9,249 |
86.8 6.0 | |||||||
Trading of raw materials used in lithium batteries | 2 | 2 | - | |||||||
Total | $27,803 | $54,458 | 95.9 | |||||||
Cost of revenues was $50.67 million, an increase of 89.4% from $26.76 million in the same period of 2021. This was primarily due to increased net revenues.
Gross profit was $3.78 million, representing an increase of 263.1% from $1.04 million in the same period of 2021. Gross margin was 6.95%, an increase of 3.2% from 3.75% in the same period of 2021.
Total operating expenses were $12.61 million, an increase of 84.7% from $6.83 million in the same period of 2021. The increase in certain expense categories was largely due to increased investments in research and development and impairment charges on acquired Hitrans' equipment and goodwill.
- Research and development expenses were $2.64 million, an increase of 36.7% from $1.93 million in the same period of 2021.
- Sales and marketing expenses were $-0.35 million, compared to the sales and marketing expenses of $1.04 million in the same period of 2021.
- General and administrative expenses were $3.18 million, a decrease of 24.3% from $4.20 million in the same period of 2021.
- Provision for doubtful accounts was $0.76 million, compared to the recovery of doubtful accounts of $0.34 million in the same period of 2021.
- Impairment charge on property, plant and equipment was $4.83 million, compared to nil in the same period of 2021.
- Impairment charge on goodwill was $1.56 million, compared to nil in the same period of 2021.
Operating loss was $8.83 million, compared to $5.79 million in the same period of 2021, representing a change of 52.6%.
Finance income, net was $0.42 million, decreased by 31.4% from $0.61 million in the same period of 2021.
Change in fair value of warrants was $1.01 million, compared to $4.63 million in the same period of 2021. The change in fair value of the warrants liability is mainly due to share price movement.
Net loss attributable to shareholders of CBAK Energy was $10.70 million, compared to net income attributable to shareholders of CBAK Energy of $9.16 million in the same period of 2021.
Net loss attributable to shareholders of CBAK Energy (after deducting change in fair value of warrants) was $11.71 million, compared to net income attributable to shareholders of CBAK Energy (after deducting change in fair value of warrants) of $4.53 million in the same period of 2021. The change was largely caused by the impairment charges on Hitrans' equipment and goodwill.
Basic and diluted loss per share were both 0.12. In comparison, basic and diluted income per share in the same period of 2021 were both $0.1.
Full Year of 2022 Financial Results
Net revenues were $248.73 million, an increase of 372.2% from $52.67 million in 2022. This was primarily due to strong sales of high-power lithium batteries and materials for use in manufacturing lithium battery.
Net Revenues by End-product Applications | 2021 | 2022 | % Change | ||||||||
Segment 1 High power lithium batteries used in: | |||||||||||
Uninterruptable supplies | $33,308 | $83,603 | 150.7 | ||||||||
Light electric vehicles | 733 | 6,415 | 774.8 | ||||||||
Electric vehicles | 244 | 4,695 | 1,825.3 | ||||||||
Segment 2 Materials for use in manufacturing of lithium battery Precursor Cathode |
9,139 8,726 |
78,680 75,331 |
760.9 763.3 | ||||||||
Trading of raw materials used in lithium batteries | 520 | 2 | -100 | ||||||||
Total | $52,670 | $248,726 | 372.2 | ||||||||
Cost of revenues was $230.63 million, an increase of 384.9% from $47.56 million in 2021. This was primarily attributed to increased net revenues.
Gross profit was $18.10 million, an increase of 254.1% from $5.11 million in 2021. Gross margin was 7.28%, a decrease of 2.42% from 2021. The change in gross margin was primarily due to the increase in raw material prices in 2022.
Total operating expenses were $29.60 million, an increase of 75.9% from $16.82 million in 2021. The increase in certain expense categories was largely due to increased investments in research and development and impairment charges on acquired Hitrans' equipment and goodwill.
- Research and development expenses were $10.64 million, an increase of 101.6% from $5.27 million in 2021.
- Sales and marketing expenses were $2.01 million, a decrease of 12.8% from $2.30 million in 2021.
- General and administrative expenses were $9.74 million, a decrease of 2.9% from $10.03 million in 2021.
- Provision for doubtful accounts was $0.83 million, compared to a recovery of doubtful accounts of $0.78 million in 2021.
- Impairment charge on property, plant and equipment was $4.83 million, compared to nil in 2021.
- Impairment charge on goodwill was $1.56 million, compared to nil in 2021.
Operating loss was $11.50 million, compared to $11.71 million in 2021, representing a decrease of 1.8%.
Finance income, net was $0.49 million, decreased by 37.4% from $0.78 million in 2021.
Change in fair value of warrants was $5.71 million, compared to $61.80 million in 2021. The change in fair value of the warrants liability is mainly due to share price movement.
Net loss attributable to shareholders of CBAK Energy was $9.45 million, compared to net income attributable to shareholders of CBAK Energy of $61.49 million in 2021.
Net loss attributable to shareholders of CBAK Energy (after deducting change in fair value of warrants) was $15.16 million, compared to a net loss attributable to shareholders of CBAK Energy (after deducting change in fair value of warrants) of $0.32 million in 2021. The change was largely caused by the impairment charges on Hitrans' equipment and goodwill, as well as surging raw material prices in 2022.
Basic and diluted loss per share were both $0.11. In comparison, basic and diluted income per share in 2021 were both $0.70.
Conference Call
CBAK's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Tuesday, April 11, 2023 (8:00 PM Beijing/Hong Kong Time on April 11, 2023).
For participants who wish to join our call online, please visit:
https://edge.media-server.com/mmc/p/cdtu7nz6
Participants who plan to ask questions at the call will need to register at least 15 minutes prior to the scheduled call start time using the link provided below. Upon registration, participants will receive the conference call access information, including dial-in numbers, a unique pin and an email with detailed instructions.
Participant Online Registration:
https://register.vevent.com/register/BI235292f7ba7c4a2486c1eea774036480
Once completing the registration, please dial-in at least 10 minutes before the scheduled start time of the conference call and enter the personal pin as instructed to connect to the call.
A replay of the conference call may be accessed within seven days after the conclusion of the live call at the following website:
https://edge.media-server.com/mmc/p/cdtu7nz6
The earnings release and the link for the replay are available at ir.cbak.com.cn.
About CBAK Energy
CBAK Energy Technology, Inc. (NASDAQ: CBAT) is a leading high-tech enterprise in China engaged in the development, manufacturing, and sales of new energy high power lithium batteries and raw materials for use in manufacturing high power lithium batteries. The applications of the Company's products and solutions include electric vehicles, light electric vehicles, electric tools, energy storage, uninterruptible power supply (UPS), and other high-power applications. In January 2006, CBAK Energy became the first lithium battery manufacturer in China listed on the Nasdaq Stock Market. CBAK Energy has multiple operating subsidiaries in Dalian, Nanjing and Shaoxing, as well as a large-scale R&D and production base in Dalian.
For more information, please visit www.cbak.com.cn.
Safe Harbor Statement
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, strategy and plans, and our expectations for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements.
Any forward-looking statements contained in this press release are only estimates or predictions of future events based on information currently available to our management and management's current beliefs about the potential outcome of future events. Whether these future events will occur as management anticipates, whether we will achieve our business objectives, and whether our revenues, operating results, or financial condition will improve in future periods are subject to numerous risks. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: significant legal and operational risks associated with having substantially all of our business operations in China, that the Chinese government may exercise significant oversight and discretion over the conduct of our business and may intervene in or influence our operations at any time, which could result in a material change in our operations and/or the value of our securities or could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and could cause the value of such securities to significantly decline or be worthless, the effects of the global Covid-19 pandemic or other health epidemics, changes in domestic and foreign laws, regulations and taxes, the volatility of the securities markets; and other risks including, but not limited to, the ability of the Company to meet its contractual obligations, the uncertain markets for the Company's products and business, macroeconomic, technological, regulatory, or other factors affecting the profitability of our products and solutions that we discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 10-K as well as in our other reports filed or furnished from time to time with the SEC. You should read these factors and the other cautionary statements made in this press release. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.
For investor and media inquiries, please contact:
CBAK Energy Technology, Inc.
Investor Relations Department
Mr. Thierry Jiewei Li
Phone: 86-18675423231
Email: ir@cbak.com.cn
CBAK Energy Technology, Inc. and Subsidiaries | |||||||||
Unaudited Condensed Consolidated Balance Sheets | |||||||||
(In $ except for number of shares) | |||||||||
December 31, | December 31, | ||||||||
Assets | |||||||||
Current assets | |||||||||
Cash and cash equivalents | $ | 7,357,875 | $ | 6,519,212 | |||||
Pledged deposits | 18,996,749 | 30,836,864 | |||||||
Trade and bills receivable, net | 49,907,129 | 27,413,575 | |||||||
Inventories | 30,133,340 | 49,446,291 | |||||||
Prepayments and other receivables | 12,746,990 | 5,915,080 | |||||||
Receivables from former subsidiary | 2,263,955 | 5,518,052 | |||||||
Amount due from non-controlling interest, current | 125,883 | - | |||||||
Amount due from related party, current | 472,061 | - | |||||||
Income tax recoverable | 47,189 | 57,934 | |||||||
Investment in sales-type lease, net | 790,516 | - | |||||||
Total current assets | 122,841,687 | 125,707,008 | |||||||
Property, plant and equipment, net | 90,042,773 | 90,004,527 | |||||||
Construction in progress | 27,343,092 | 9,954,202 | |||||||
Non-marketable equity securities | 712,930 | 945,237 | |||||||
Prepaid land use rights | 13,797,230 | 12,361,163 | |||||||
Intangible assets, net | 1,961,739 | 1,309,058 | |||||||
Operating lease right-of-use assets, net | 1,968,032 | 1,264,560 | |||||||
Investment in sales-type lease, net | 838,528 | - | |||||||
Amount due from non-controlling interest, non-current | 62,941 | - | |||||||
Deferred tax assets, net | 1,403,813 | 2,486,979 | |||||||
Goodwill | 1,645,232 | - | |||||||
Total assets | $ | 262,617,997 | $ | 244,032,734 | |||||
Liabilities | |||||||||
Current liabilities | |||||||||
Trade and bills payable | $ | 65,376,212 | $ | 67,491,435 | |||||
Short-term bank borrowings | 8,811,820 | 14,907,875 | |||||||
Other short-term loans | 4,679,122 | 689,096 | |||||||
Accrued expenses and other payables | 22,963,700 | 25,605,661 | |||||||
Payable to a former subsidiary, net | 326,507 | 358,067 | |||||||
Deferred government grants, current | 3,834,481 | 1,299,715 | |||||||
Product warranty provisions | 127,837 | 26,215 | |||||||
Warrants liability | 5,846,000 | 136,000 | |||||||
Operating lease liability, current | 801,797 | 575,496 | |||||||
Finance lease liability, current | - | 844,297 | |||||||
Total current liabilities | 112,767,476 | 111,933,857 | |||||||
Deferred government grants, non-current | 6,189,196 | 5,577,020 | |||||||
Product warranty provisions | 1,900,429 | 450,613 | |||||||
Operating lease liability, non-current | 876,323 | 607,222 | |||||||
Accrued expenses and other payables, non-current | - | 1,085,525 | |||||||
Total liabilities | 121,733,424 | 119,654,237 | |||||||
Commitments and contingencies | |||||||||
Shareholders' equity | |||||||||
Common stock $0.001 par value; 500,000,000 authorized; 88,849,222 | 88,849 | 89,135 | |||||||
Donated shares | 14,101,689 | 14,101,689 | |||||||
Additional paid-in capital | 241,946,362 | 246,240,998 | |||||||
Statutory reserves | 1,230,511 | 1,230,511 | |||||||
Accumulated deficit | (122,498,259) | (131,946,705) | |||||||
Accumulated other comprehensive loss | 2,489,017 | (8,153,644) | |||||||
137,358,169 | 121,561,984 | ||||||||
Less: Treasury shares | (4,066,610) | (4,066,610) | |||||||
Total shareholders' equity | 133,291,559 | 117,495,374 | |||||||
Non-controlling interests | 7,593,014 | 6,883,123 | |||||||
Total equity | 140,884,573 | 124,378,497 | |||||||
Total liabilities and shareholder's equity | $ | 262,617,997 | $ | 244,032,734 |
CBAK Energy Technology, Inc. and Subsidiaries | ||||||||||
Unaudited Condensed Consolidated Statements of Operations and Comprehensive | ||||||||||
(In $ except for number of shares) | ||||||||||
Year ended | Year ended | |||||||||
December 31, | December 31, | |||||||||
Net revenues | $ | 52,669,733 | $ | 248,725,485 | ||||||
Cost of revenues | (47,559,243) | (230,630,161) | ||||||||
Gross profit | 5,110,490 | 18,095,324 | ||||||||
Operating expenses: | ||||||||||
Research and development expenses | (5,274,316) | (10,635,486) | ||||||||
Sales and marketing expenses | (2,301,720) | (2,007,812) | ||||||||
General and administrative expenses | (10,027,349) | (9,737,711) | ||||||||
Impairment charge on property, plant and equipment | - | (4,831,708) | ||||||||
Impairment charge on goodwill | - | (1,556,078) | ||||||||
Recovery of (provision for) doubtful accounts | 780,389 | (831,132) | ||||||||
Total operating expenses | (16,822,996) | (29,599,927) | ||||||||
Operating loss | (11,712,506) | (11,504,603) | ||||||||
Finance income, net | 784,880 | 491,060 | ||||||||
Other income (expenses), net | 3,644,363 | (7,252,475) | ||||||||
Impairment of non-marketable equity securities | (692,639) | - | ||||||||
Changes in fair value of warrants liability | 61,802,000 | 5,710,000 | ||||||||
Income (loss) before income tax | 53,826,098 | (12,556,018) | ||||||||
Income tax credit, net | 7,733,046 | 1,228,207 | ||||||||
Net income (loss) | 61,559,144 | (11,327,811) | ||||||||
Less: Net (income) loss attributable to non-controlling interests | (73,092) | 1,879,365 | ||||||||
Net income (loss) attributable to shareholders of CBAK Energy | $ | 61,486,052 | $ | (9,448,446) | ||||||
Net income (loss) | 61,559,144 | (11,327,811) | ||||||||
Other comprehensive income (loss) | ||||||||||
– Foreign currency translation adjustment | 2,725,768 | (11,189,175) | ||||||||
Comprehensive income (loss) | 64,284,912 | (22,516,986) | ||||||||
Less: Comprehensive (income) loss attributable to non-controlling | (70,234) | 2,425,879 | ||||||||
Comprehensive income (loss) attributable to CBAK Energy | $ | 64,214,678 | $ | (20,091,107) | ||||||
Income (Loss) per share | ||||||||||
– Basic | $ | 0.70 | $ | (0.11) | ||||||
– Diluted | $ | 0.70 | $ | (0.11) | ||||||
Weighted average number of shares of common stock: | ||||||||||
– Basic | 87,605,493 | 88,927,671 | ||||||||
– Diluted | 87,884,357 | 88,927,671 | ||||||||
* Less than $0.01 per share |